Title : [Effects of proteasome inhibitor bortezomib on NF-kappaB activity and ICAM-1 mRNA expression of K562 cells].

Pub. Date : 2008 Oct

PMID : 18928584






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 [Effects of proteasome inhibitor bortezomib on NF-kappaB activity and ICAM-1 mRNA expression of K562 cells]. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
2 This study was aimed to investigate the effects of proteasome inhibitor bortezomib (Velcade, PS-341) on the activation of NF-kappaB and the expression of intercellular adhesion molecule-1 (ICAM-1) in K562 cells. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
3 This study was aimed to investigate the effects of proteasome inhibitor bortezomib (Velcade, PS-341) on the activation of NF-kappaB and the expression of intercellular adhesion molecule-1 (ICAM-1) in K562 cells. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
4 This study was aimed to investigate the effects of proteasome inhibitor bortezomib (Velcade, PS-341) on the activation of NF-kappaB and the expression of intercellular adhesion molecule-1 (ICAM-1) in K562 cells. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
5 The results showed that the activation of NF-kappaB and the expression of ICAM-1 in K562 cells decreased significantly after bortezomib treatment. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
6 It is concluded that proteasome inhibitor bortezomib downregulates the expression of K562 cell ICAM-1 by inhibiting the activity of NF-kappaB, which provides a new way for the target therapy in acute leukemia. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens